Table 2.
Correlations between biomarkers indexed to urinary creatinine and clinical traits
| Biomarker | Age | BMI | SBP | Glucose | HDL Cholesterol | Triglycerides | eGFR | Cystatin C | UACRa |
|---|---|---|---|---|---|---|---|---|---|
| α1-microglobulin | 0.14b | −0.04c | 0.12b | 0.10b | −0.05d | 0.06b | −0.09b | 0.21b | 0.22b |
| β2-microglobulin | 0.06b | −0.002 | 0.05c | 0.04c | −0.04c | 0.03 | −0.09b | 0.21b | 0.16b |
| Calbindin | 0.06b | 0.007 | 0.08b | 0.01 | −0.008 | −0.005 | −0.008 | −0.01 | 0.12b |
| Clusterin | 0.03 | −0.05c | 0.002 | −0.06b | 0.07b | −0.04c | −0.001 | −0.04c | 0.10b |
| CTGF | 0.07b | −0.05d | 0.02 | −0.03 | 0.06d | −0.04 | 0.04 | 0.03 | 0.13b |
| Cystatin-C | 0.04c | 0.004 | 0.04c | 0.01 | −0.02 | 0.03 | −0.09b | 0.16b | 0.13b |
| GST-α | 0.03 | −0.01 | 0.02 | −0.01 | 0.02 | −0.03 | −0.02 | 0.01 | 0.07b |
| Kim-1 | 0.19b | 0.02 | 0.13b | 0.08b | 0.003 | 0.05d | −0.03 | 0.17b | 0.19b |
| NGAL | 0.06b | −0.02 | 0.02 | 0.01 | 0.04c | 0.03 | −0.06d | 0.04 | 0.15b |
| Osteopontin | 0.01 | 0.06d | 0.006 | 0.02 | −0.05d | 0.001 | 0.04c | −0.03 | −0.17 |
| TFF-3 | 0.02 | −0.08b | 0.02 | 0.008 | 0.10b | 0.03 | −0.06d | 0.07b | 0.001 |
| Tamm–Horsfall Protein | 0.02 | −0.12b | −0.02 | −0.13b | 0.16b | −0.08b | 0.04 | −0.09b | 0.02 |
| TIMP-1 | 0.04c | −0.001 | 0.01 | 0.02 | −0.03 | −0.02 | −0.03 | 0.02 | 0.06b |
| VEGF | 0.07b | −0.04c | 0.03 | −0.004 | −0.04c | −0.02 | −0.05c | 0.05d | 0.10b |
SBP, systolic BP; TIMP-1, tissue inhibitor of matrix metalloproteinase-1; VEGF, vascular endothelial growth factor.
To avoid spurious correlation caused by creatinine being the denominator in both cases, the correlation with biomarker unindexed to urinary creatinine is presented for UACR.
P<0.001.
P<0.05.
P<0.01.